Takeda Pharmaceutical Li... (TAK)
NYSE: TAK
· Real-Time Price · USD
14.98
0.18 (1.22%)
At close: Aug 15, 2025, 2:53 PM
Takeda Pharmaceutical Ratios and Metrics
Financials in JPY. Fiscal
year is
April - March.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
PE Ratio | -17.09 | 69.39 | 17.56 | 17.24 | -538.67 | 14.92 | -37.64 | 19.71 | 54.61 | 13.34 | 23.60 | 14.02 | -119.16 | 21.25 | 31.16 | 10.50 |
PEG Ratio | 0.03 | -0.94 | -4.15 | -0.01 | 5.24 | -0.05 | 0.25 | 0.11 | -0.74 | 0.14 | -0.57 | -0.01 | 0.99 | 0.81 | -0.46 | -0.36 |
PS Ratio | 6.70 | 5.77 | 5.50 | 5.44 | 6.19 | 5.68 | 6.93 | 6.66 | 7.11 | 5.80 | 5.81 | 6.05 | 6.20 | 5.45 | 6.78 | 6.09 |
PB Ratio | 1.02 | 0.89 | 0.93 | 0.84 | 0.89 | 0.94 | 1.02 | 1.02 | 1.07 | 1.03 | 0.87 | 0.93 | 0.95 | 0.92 | 1.08 | 1.10 |
P/FCF Ratio | 40.68 | 19.50 | 30.86 | 304.46 | 31.24 | 91.04 | 56.12 | -39.85 | -45.22 | 19.41 | 32.31 | -416.55 | 16.72 | 16.42 | 30.20 | 46.40 |
P/OCF Ratio | 31.75 | 17.20 | 24.97 | 41.22 | 23.87 | 43.10 | 36.36 | 76.26 | 23.16 | 16.81 | 26.37 | 69.89 | 14.41 | 14.13 | 24.57 | 34.64 |
OCF/S Ratio | 0.21 | 0.34 | 0.22 | 0.13 | 0.26 | 0.13 | 0.19 | 0.09 | 0.31 | 0.34 | 0.22 | 0.09 | 0.43 | 0.39 | 0.28 | 0.18 |
Debt / Equity Ratio | 0.73 | 0.73 | 0.73 | 0.70 | 0.67 | 0.69 | 0.66 | 0.69 | 0.69 | 0.69 | 0.71 | 0.73 | 0.76 | 0.82 | 0.79 | 0.84 |
Quick Ratio | 0.52 | 0.72 | 0.77 | 0.74 | 0.58 | 0.55 | 0.55 | 0.56 | 0.57 | 0.75 | 0.75 | 0.75 | 0.81 | 0.92 | 0.87 | 0.99 |
Current Ratio | 1.01 | 1.31 | 1.28 | 1.26 | 1.11 | 1.06 | 1.04 | 0.99 | 0.97 | 1.16 | 1.15 | 1.18 | 1.21 | 1.37 | 1.28 | 1.45 |
Asset Turnover | 0.07 | 0.08 | 0.08 | 0.07 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 |
Interest Coverage | n/a | n/a | 2.69 | 3.68 | 0.01 | 1.58 | -1.06 | 2.83 | 2.06 | 1.84 | 1.94 | 2.71 | n/a | 2.49 | 2.46 | 3.50 |
Return on Equity | -0.01 | n/a | 0.01 | 0.01 | n/a | 0.02 | -0.01 | 0.01 | n/a | 0.02 | 0.01 | 0.02 | n/a | 0.01 | 0.01 | 0.03 |
Return on Assets | -0.01 | n/a | 0.01 | 0.01 | n/a | 0.01 | n/a | 0.01 | n/a | 0.01 | n/a | 0.01 | n/a | n/a | n/a | 0.01 |
Return on Invested Capital | -0.01 | n/a | 0.01 | 0.01 | n/a | 0.01 | n/a | 0.01 | n/a | 0.01 | 0.01 | 0.01 | n/a | 0.01 | 0.01 | 0.01 |
Dividend Yield | 0.00 | 0.02 | 0.00 | 0.02 | 0.00 | 0.02 | 0.00 | 0.02 | 0.00 | 0.02 | 0.00 | 0.02 | 0.00 | 0.03 | 0.00 | 0.02 |
Payout Ratio | -0.09 | 6.11 | 0.10 | 1.45 | -3.02 | 1.31 | -0.19 | 1.46 | 0.33 | 1.08 | 0.18 | 1.23 | -0.94 | 2.28 | 0.21 | 0.96 |
Gross Profit Margin | 0.64 | 0.64 | 0.54 | 0.54 | 0.46 | 0.66 | 0.67 | 0.70 | 0.68 | 0.69 | 0.70 | 0.70 | 0.65 | 0.69 | 0.67 | 0.75 |
Net Profit Margin | -0.1 | 0.02 | 0.08 | 0.08 | -0.00 | 0.10 | -0.05 | 0.08 | 0.03 | 0.11 | 0.06 | 0.11 | -0.01 | 0.06 | 0.05 | 0.14 |
Pretax Profit Margin | -0.1 | 0.02 | 0.10 | 0.11 | -0.05 | 0.06 | -0.09 | 0.13 | 0.05 | 0.10 | 0.06 | 0.16 | -0.06 | 0.08 | 0.07 | 0.23 |
Operating Profit Margin | -0.07 | 0.06 | 0.16 | 0.18 | 0.00 | 0.09 | -0.05 | 0.16 | 0.09 | 0.13 | 0.10 | 0.15 | -0.00 | 0.13 | 0.12 | 0.26 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | 0.17 | 0.17 | 0.32 | 0.32 | 0.18 | 0.26 | 0.19 | 0.33 | 0.27 | 0.30 | 0.27 | 0.33 | 0.15 | 0.29 | 0.28 | 0.41 |